Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nociceptive afferent neurons are sensory nerve fibers responsible for detecting and transmitting signals from damaged tissue or threats of damage to the central nervous system, initiating pain sensation[1][3][6]. There are several classes of such fibers—primarily the Aδ (thinly myelinated, fast-conducting) and C fibers (unmyelinated, slow-conducting)—that differ in their conduction velocities and stimulus sensitivities[1][5][3]. These neurons utilize specific ion channels (e.g., various TRP channels, voltage-gated sodium channels), and their subpopulations can be further classified by neuropeptide expression (peptidergic vs. non-peptidergic)[3][5]. They play crucial roles not only in pain perception but also in neurogenic inflammation and modulation of immune responses[3]. Drugs targeting these neurons (e.g., sodium channel blockers, TRPV1 antagonists, opioids) aim to reduce pain transmission, but therapeutic manipulation must balance analgesia with avoidance of sensory loss and chronic pain conversion[4][3]. Summary of interpretation and limitations: "Nociceptive nerve afferents" is not a molecular target like a receptor, transporter, or enzyme, but rather refers to a population of neurons. For structured databases, nociceptor subtypes or the specific ion channels/receptors they express (e.g., TRPV1, Nav1.7) would represent conventional molecular targets.
Blocking ion channels involved in signal transduction (e.g., voltage-gated sodium channels, TRP channels) Inhibiting neurotransmitter release (e.g., substance P, CGRP) to reduce neurogenic inflammation and pain signaling Modulation of receptor activity on nociceptors
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nociceptive afferent neuron (None (commonly "nociceptor" as a shortened form, but not a formal abbreviation)).